CMA had the opportunity to meet with approximately 900 veterinarians from all across Turkey at the Congress held by the Farm Animal Veterinary Medicine Association at the Titanic Hotel Antalya between October 12-15, 2017.
Despite being a new company with only 1.5 years of operation, CMA has participated in similar international congresses for the third time, placing support for scientific congresses among its strategic objectives.
The congress content’s appeal to farm veterinarians and private practitioners was evident from the intense participation of veterinarians working in this field.
The congress, held with presentations by foreign and domestic experts, was scientifically rich with clinical studies presented on farm animals. The exchange of information with sector stakeholders at the congress and the heavily visited exhibition area allowed for discussion of various topics and shaped positive expectations for the future.
In today’s era where industrial production takes precedence, preventive medicine occupies a more prominent place than treatment. Eliminating effective factors to prevent economic loss falls within the scope of preventive medicine. Besides preventive medicine, the importance of nutrition is quite significant; Prof. Dr. Hakan Biricik’s presentation on “Nutrition of Tomorrow’s Dairy Cattle: Calf 4.0” was particularly engaging.
The global movement to reduce antibiotic use in animal health continues to strengthen, particularly in the United States and Europe. In eliminating antibiotics and fully protecting intestinal health, probiotics, organic acids, enzymes, etc. come to the forefront.
At the CMA congress stand:
Under the concept of “Discover the Future,” CMA explained its goal of improving animal health through biotechnological techniques using probiotics and bioferments related to intestinal health, referred to as the “second brain” in animal husbandry, and developing products and new methods that will contribute to the country’s economy.
With the slogan “If You Protect the Intestines, You Protect the Whole Body,” the company introduced ZymFlor Ruminant, a product containing probiotics, prebiotics, and enzymes, for the first time in ruminants at its stand.
CMA continues its efforts to obtain the title of first and sole company to market probiotics isolated from domestic intestinal flora separately in all animal groups.
Recognizing that calf, lamb, and kid diarrhea—the future of livestock farming in Turkey—causes irreversible losses and even deaths, CMA introduced Zoentero, a product containing probiotics and bioferments derived from ruminant intestinal flora, at the congress stand. The company works to ensure that this next-generation biotechnological product fully supports the thesis of “calves must not die” in maintaining complete intestinal health and provides significant contribution to the country’s economy. Healthy calves, lambs, and kids will be the healthy generations of the future.
In ruminants, CMA presented Bio-AminoVit Ruminant, an effervescent powder product with a quadruple combination consisting of prebiotics, vitamins, minerals, and amino acids that will provide animals with high resistance under all adverse living conditions at the congress stand.
Additionally, the company presented biotechnological products with specific characteristics at the congress: Super 7, a cicatrizant and umbilical cord drying agent from the USA; Boviferm Plus from Germany supporting calf fluid electrolyte needs; ZoeMint Cream and spray supporting udder health; and Inchoof Gel from the Netherlands supporting hoof health.
In accordance with CMA’s vision, the company has targeted the supply of preventive medicine products to veterinarians. In this direction, by keeping pace with rapidly changing market conditions and continuously renewing itself, CMA will continue to contribute to its sector.
As CMA, the company will continue to grow in the sector by always remaining close to veterinarians and delivering support and services to veterinarians working throughout Turkey.
Ahmet ÇELİKOĞLU
Field Manager
CMA Biotechnology and Pharmaceutical Co., Inc.